Stereotaxis, Inc.
STXSNYSECIK 1289340HealthcareFiscal year ends Dec 31
Reports and events: 340 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1216:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037357 |
| 2026-08-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037113 |
| 2026-07-1617:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-033405 |
| 2026-07-0908:13 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032598 |
| 2026-05-1515:31 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-023654 |
| 2026-05-1315:42 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022697 |
| 2026-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022488 |
| 2026-04-1507:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016685 |
| 2026-04-0317:00 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-015172 |
| 2026-04-0306:04 ET | DEF 14A | Proxy statementPeriod 2026-04-03 | 0001493152-26-015027 |
| 2026-03-1216:52 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-009881 |
| 2026-03-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-009366 |
| 2025-11-1215:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021881 |
| 2025-11-1209:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021772 |
| 2025-08-2917:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-026031 |
| 2025-08-1315:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023417 |
| 2025-08-0716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022580 |
| 2025-07-1708:56 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019990 |
| 2025-07-1708:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001641172-25-019985 |
| 2025-05-1912:13 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-011415 |
| 2025-05-1316:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009933 |
| 2025-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009667 |
| 2025-04-0416:00 ET | DEF 14A | Proxy statementPeriod 2025-04-04 | 0001641172-25-002746 |
| 2025-03-1416:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-010352 |
| 2025-03-0307:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-008810 |
| 2024-11-1416:49 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045994 |
| 2024-11-1209:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044573 |
| 2024-08-1413:40 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032047 |
| 2024-08-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031266 |
| 2024-08-0209:05 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001493152-24-029986 |
| 2024-07-1817:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-028364 |
| 2024-05-1617:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001493152-24-020281 |
| 2024-05-1510:35 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019608 |
| 2024-05-1316:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-018881 |
| 2024-04-0415:50 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001493152-24-013167 |
| 2024-03-0815:21 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-009371 |
| 2024-03-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-008704 |
| 2023-11-1309:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040354 |
| 2023-11-0909:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040008 |
| 2023-08-1109:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027738 |
| 2023-08-1009:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027465 |
| 2023-06-1516:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-021433 |
| 2023-05-1917:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-018391 |
| 2023-05-1217:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016720 |
| 2023-05-0909:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-015876 |
| 2023-04-0516:05 ET | DEF 14A | Proxy statementPeriod 2023-04-05 | 0001493152-23-011022 |
| 2023-03-0915:38 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-007106 |
| 2023-03-0309:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-006634 |
| 2022-11-1411:03 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031744 |
| 2022-11-1009:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-031248 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.